Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-25

FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., indicating a supplemental approval for this long-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal Consta (risperidone long-acting injectable)

Snippet

SUPPL AP for RISPERDAL CONSTA (RISPERIDONE)